Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - IRISH TOP 8.3 REPORT - UDG Healthcare plc

21st May 2021 12:18

 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

 Name of person dealing (Note 1)Barclays PLC.
 Company dealt inUDG HEALTHCARE PLC
 Class of relevant security to which the ORD
 dealings being disclosed relate (Note 2)
 Date of dealing20 May 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD  
 

Long

Short

 

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

 

3,898,969

1.55%

140,863

0.06%

  

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

 

80,078

0.03%

3,376,350

1.34%

  

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

 

TOTAL:

 

 

 

 

 

3,979,047

1.58%

3,517,213

1.40%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

185

10.2460 GBP

Purchase

289

10.2450 GBP

Purchase

884

10.2500 GBP

Purchase

884

10.2489 GBP

Purchase

1,552

10.2455 GBP

Purchase

3,210

10.2394 GBP

Purchase

3,895

10.2578 GBP

Purchase

4,532

10.2436 GBP

Purchase

6,228

10.2435 GBP

Purchase

7,037

10.2400 GBP

Purchase

7,619

10.2416 GBP

Purchase

10,529

10.2521 GBP

Purchase

12,132

10.2522 GBP

Purchase

16,396

10.2515 GBP

Purchase

17,229

10.2506 GBP

Purchase

17,245

10.2487 GBP

Purchase

52,067

10.2600 GBP

Purchase

116,581

10.2439 GBP

Purchase

129,851

10.2473 GBP

Sale

269

10.2600 GBP

Sale

289

10.2453 GBP

Sale

289

10.2450 GBP

Sale

759

10.2415 GBP

Sale

1,158

10.2479 GBP

Sale

3,374

10.2423 GBP

Sale

5,215

10.2500 GBP

Sale

5,439

10.2400 GBP

Sale

8,884

10.2475 GBP

Sale

10,000

10.2443 GBP

Sale

10,159

10.2503 GBP

Sale

112,025

10.2446 GBP

Sale

150,000

10.2550 GBP

(b) Derivatives transactions (other than options transactions)

Product Name

Nature of transaction

Number of relevant securities

Price per

 

 

 

unit

CFD

Long

110

10.2416 GBP

CFD

Long

649

10.2415 GBP

SWAP

Long

1,881

10.2600 GBP

SWAP

Long

2,819

10.2404 GBP

SWAP

Long

9,818

10.2528 GBP

SWAP

Long

11,344

10.2497 GBP

CFD

Short

158

10.2436 GBP

SWAP

Short

185

10.2460 GBP

SWAP

Short

1,552

10.2455 GBP

SWAP

Short

2,572

10.2430 GBP

CFD

Short

3,498

10.2435 GBP

SWAP

Short

7,619

10.2416 GBP

SWAP

Short

29,765

10.2439 GBP

SWAP

Short

30,216

10.2500 GBP

SWAP

Short

48,525

10.2435 GBP

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

21 May 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected 
If a connected EFM, state nature of connection 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210521005221/en/

Copyright Business Wire 2021


Related Shares:

BarclaysUDG.L
FTSE 100 Latest
Value8,275.66
Change0.00